Literature DB >> 24583625

MTHFR C677T/A1298C genotype: a possible risk factor for liver sinusoidal obstruction syndrome.

E Efrati1, T Zuckerman2, E Ben-Ami3, N Krivoy4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24583625     DOI： 10.1038/bmt.2014.16

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  11 in total

1.  Influence of glutathione S-transferase A1, P1, M1, T1 polymorphisms on oral busulfan pharmacokinetics in children with congenital hemoglobinopathies undergoing hematopoietic stem cell transplantation.

Authors:  Ronit Elhasid; Norberto Krivoy; Jacob M Rowe; Eli Sprecher; Lior Adler; Hela Elkin; Edna Efrati
Journal:  Pediatr Blood Cancer       Date:  2010-12-01       Impact factor: 3.167

2.  Identification of gene expression signatures for molecular classification in human leukemia cells.

Authors:  Ju Han Song; Hyeoung-Joon Kim; Chang Hyun Lee; Seung Jun Kim; Seung Yong Hwang; Tae Sung Kim
Journal:  Int J Oncol       Date:  2006-07       Impact factor: 5.650

3.  Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes.

Authors:  L D DeLeve; X Wang
Journal:  Pharmacology       Date:  2000-04       Impact factor: 2.547

4.  A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations.

Authors:  G Friedman; N Goldschmidt; Y Friedlander; A Ben-Yehuda; J Selhub; S Babaey; M Mendel; M Kidron; H Bar-On
Journal:  J Nutr       Date:  1999-09       Impact factor: 4.798

Review 5.  Busulfan in hematopoietic stem cell transplant setting.

Authors:  Jeannine S McCune; Leona A Holmberg
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-08       Impact factor: 4.481

6.  Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation.

Authors:  Eray Goekkurt; Jan Stoehlmacher; Christian Stueber; Christine Wolschke; Thomas Eiermann; Simona Iacobelli; Axel R Zander; Gerhard Ehninger; Nicolaus Kröger
Journal:  Anticancer Res       Date:  2007 Nov-Dec       Impact factor: 2.480

7.  Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors.

Authors:  G B McDonald; P Sharma; D E Matthews; H M Shulman; E D Thomas
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

8.  Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics.

Authors:  J T Slattery; J E Sanders; C D Buckner; R L Schaffer; K W Lambert; F P Langer; C Anasetti; W I Bensinger; L D Fisher; F R Appelbaum
Journal:  Bone Marrow Transplant       Date:  1995-07       Impact factor: 5.483

9.  Redox regulation of homocysteine-dependent glutathione synthesis.

Authors:  Victor Vitvitsky; Eugene Mosharov; Michael Tritt; Fazoil Ataullakhanov; Ruma Banerjee
Journal:  Redox Rep       Date:  2003       Impact factor: 4.412

10.  Pharmacokinetic and pharmacogenetic analysis of oral busulfan in stem cell transplantation: prediction of poor drug metabolism to prevent drug toxicity.

Authors:  Norberto Krivoy; Tsila Zuckerman; Hela Elkin; Lia Froymovich; Jacob M Rowe; Edna Efrati
Journal:  Curr Drug Saf       Date:  2012-07
View more
  4 in total

1.  Association between MTHFR A1298C polymorphism and hepatocellular carcinoma risk.

Authors:  Haiyan Zhang; Guang Li; Zhen Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  Genetic Predictors for Sinusoidal Obstruction Syndrome-A Systematic Review.

Authors:  Nicolas Waespe; Sven Strebel; Simona Jurkovic Mlakar; Maja Krajinovic; Claudia Elisabeth Kuehni; Tiago Nava; Marc Ansari
Journal:  J Pers Med       Date:  2021-04-26

3.  Biomarkers for hepatic sinusoidal obstruction syndrome after hematopoietic cell transplantation.

Authors:  Je-Hwan Lee
Journal:  Blood Res       Date:  2015-09-22

4.  Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.

Authors:  M Mohty; F Malard; M Abecassis; E Aerts; A S Alaskar; M Aljurf; M Arat; P Bader; F Baron; A Bazarbachi; D Blaise; F Ciceri; S Corbacioglu; J-H Dalle; F Dignan; T Fukuda; A Huynh; T Masszi; M Michallet; A Nagler; M NiChonghaile; S Okamoto; A Pagliuca; C Peters; F B Petersen; P G Richardson; T Ruutu; B N Savani; E Wallhult; I Yakoub-Agha; R F Duarte; E Carreras
Journal:  Bone Marrow Transplant       Date:  2016-05-16       Impact factor: 5.483
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.